Stocktoria

ONCOLYTICS BIOTECH INC ONCY

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2001-10-05

ONCOLYTICS BIOTECH INC statistics & valuation

Market cap$158.6M
Return on capital-1939.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
-691.10% 20242025
Shares outstanding
80.0M 108.0M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-169.80% -379.30% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$0.30 -$0.30 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-379.3%-169.8%
Return on equity757.0%-691.1%
Current ratio1.122.55

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.